Julie Ducharme

1.9k total citations
45 papers, 1.3k citations indexed

About

Julie Ducharme is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Julie Ducharme has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 15 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Julie Ducharme's work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (9 papers) and Analytical Chemistry and Chromatography (6 papers). Julie Ducharme is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (9 papers) and Analytical Chemistry and Chromatography (6 papers). Julie Ducharme collaborates with scholars based in Canada, United States and France. Julie Ducharme's co-authors include Robert Farinotti, Denis Projean, Irving W. Wainer, France Varin, Claude Dagenais, François Donati, David R. Bevan, Yves Théorêt, Anne‐Marie Taburet and Tao Tu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Julie Ducharme

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Ducharme Canada 20 341 323 272 221 185 45 1.3k
Jan‐Olof Svensson Sweden 22 438 1.3× 239 0.7× 162 0.6× 231 1.0× 121 0.7× 40 1.5k
Julien Déglon Switzerland 22 474 1.4× 333 1.0× 197 0.7× 273 1.2× 169 0.9× 36 1.5k
Koujirou Yamamoto Japan 22 493 1.4× 267 0.8× 403 1.5× 179 0.8× 159 0.9× 102 1.4k
Achiel Van Peer Belgium 19 319 0.9× 208 0.6× 202 0.7× 215 1.0× 179 1.0× 43 1.2k
J.F. Ménez France 19 416 1.2× 270 0.8× 128 0.5× 75 0.3× 81 0.4× 42 1.2k
Edward J. Randinitis United States 18 232 0.7× 231 0.7× 265 1.0× 194 0.9× 74 0.4× 43 1.3k
Michel Eichelbaum Germany 10 790 2.3× 286 0.9× 395 1.5× 136 0.6× 126 0.7× 12 1.3k
Yukio Kuroiwa Japan 21 699 2.0× 522 1.6× 345 1.3× 283 1.3× 50 0.3× 79 1.6k
Gladys R. Rios United States 15 771 2.3× 511 1.6× 376 1.4× 198 0.9× 109 0.6× 28 1.7k
Krista Laine Finland 26 364 1.1× 602 1.9× 496 1.8× 569 2.6× 44 0.2× 44 2.1k

Countries citing papers authored by Julie Ducharme

Since Specialization
Citations

This map shows the geographic impact of Julie Ducharme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Ducharme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Ducharme more than expected).

Fields of papers citing papers by Julie Ducharme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Ducharme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Ducharme. The network helps show where Julie Ducharme may publish in the future.

Co-authorship network of co-authors of Julie Ducharme

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Ducharme. A scholar is included among the top collaborators of Julie Ducharme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Ducharme. Julie Ducharme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almhjell, Patrick J., Kadina E. Johnston, Nicholas J. Porter, et al.. (2024). The β-subunit of tryptophan synthase is a latent tyrosine synthase. Nature Chemical Biology. 20(8). 1086–1093. 16 indexed citations
2.
Yang, Jason, et al.. (2023). DeCOIL: Optimization of Degenerate Codon Libraries for Machine Learning-Assisted Protein Engineering. ACS Synthetic Biology. 12(8). 2444–2454. 13 indexed citations
3.
Walles, Markus, et al.. (2007). Comparison of sub‐2‐μm particle columns for fast metabolite ID. Journal of Separation Science. 30(8). 1191–1199. 22 indexed citations
4.
5.
Projean, Denis, Bruno Baune, Robert Farinotti, et al.. (2003). IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION. Drug Metabolism and Disposition. 31(6). 748–754. 133 indexed citations
6.
Roy, Caroline, et al.. (2002). Synthesis and structure–activity relationship of novel aminotetralin derivatives with high μ selective opioid affinity. Bioorganic & Medicinal Chemistry Letters. 12(21). 3141–3143. 7 indexed citations
7.
8.
Ducharme, Julie, et al.. (2000). The effects of δ agonists on locomotor activity in habituated and non-habituated rats. Life Sciences. 67(8). 913–922. 15 indexed citations
9.
Ducharme, Julie & Robert Farinotti. (1997). Rapid and simple method to determine chloroquine and its desethylated metabolites in human microsomes by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 698(1-2). 243–250. 31 indexed citations
10.
Ducharme, Julie, Christine Fernandez, François Gimenez, & Robert Farinotti. (1996). Critical issues in chiral drug analysis in biological fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 686(1). 65–75. 23 indexed citations
11.
Ducharme, Julie & Robert Farinotti. (1996). Clinical Pharmacokinetics and Metabolism of Chloroquine. Clinical Pharmacokinetics. 31(4). 257–274. 222 indexed citations
12.
Wainer, Irving W., Julie Ducharme, & Camille Granvil. (1996). The N -dechloroethylation of ifosfamide: using stereochemistry to obtain an accurate picture of a clinically relevant metabolic pathway. Cancer Chemotherapy and Pharmacology. 37(4). 332–336. 23 indexed citations
13.
Ducharme, Julie, et al.. (1996). Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity. Journal of Chromatography B Biomedical Sciences and Applications. 678(1). 113–128. 77 indexed citations
14.
Ducharme, Julie, France Varin, & François Donati. (1995). Pharmacokinetics and Pharmacodynamics of a Second Dose of Atracurium† in Anaesthetised Patients. Clinical Drug Investigation. 9(2). 98–110. 8 indexed citations
15.
16.
Ducharme, Julie & François Donati. (1993). PHARMACOKINETICS AND PHARMACODYNAMICS OF STEROIDAL MUSCLE RELAXANTS. Anesthesiology Clinics of North America. 11(2). 283–308. 16 indexed citations
17.
Ducharme, Julie, France Varin, David R. Bevan, F. Donati, & Yves Théorêt. (1992). High-performance liquid chromatography—electrochemical detection of vecuronium and its metabolites in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 573(1). 79–86. 25 indexed citations
18.
Varin, France, et al.. (1991). Pharmacokinetics and pharmacodynamics of atracurium obtained with arterial and venous blood samples. Clinical Pharmacology & Therapeutics. 49(5). 515–522. 39 indexed citations
19.
Varin, France, Julie Ducharme, Yves Théorêt, et al.. (1990). Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clinical Pharmacology & Therapeutics. 48(1). 18–25. 56 indexed citations
20.
Varin, France, Julie Ducharme, Jean‐Guy Besner, & Yves Théorêt. (1990). Determination of atracurium and laudanosine in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 529(2). 319–327. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan‐Olof Svensson Breakdown of academic impact, for papers by Julien Déglon Breakdown of academic impact, for papers by Koujirou Yamamoto Breakdown of academic impact, for papers by Achiel Van Peer Breakdown of academic impact, for papers by J.F. Ménez Breakdown of academic impact, for papers by Edward J. Randinitis Breakdown of academic impact, for papers by Michel Eichelbaum Breakdown of academic impact, for papers by Yukio Kuroiwa Breakdown of academic impact, for papers by Gladys R. Rios Breakdown of academic impact, for papers by Krista Laine
Rankless by CCL
2026